Subscribe to MDT Magazine News

New Study Finds Temporal Artery Thermometry Equivalent to Rectal Thermometry

February 15, 2011 6:36 am | by Bio-Medicine.Org | Comments

WATERTOWN, Mass., Feb. 15, 2011 /- Measuring the body temperatures of newborns with temporal artery thermometry is as accurate as using rectal thermometers, according to a cross-sectional study recently published in Paediatrica Indonesiana.  Quick, safe and accurate thermometry...


NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision on Grifols Acquisition

February 15, 2011 6:35 am | by Bio-Medicine.Org | Comments

RESEARCH TRIANGLE PARK, N.C., Feb. 15, 2011 /- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR ) announced today that NASDAQ has removed TLCR from the NASDAQ Biotechnology Index(R) (Nasdaq: NBI) in anticipation of the company's pending acquisition by Grifols S.A. The change takes...


Jefferson researchers provide genetic evidence that antioxidants can help treat cancer

February 15, 2011 6:34 am | by EurekAlert | Comments

(Thomas Jefferson University) Researchers from Jefferson's Kimmel Cancer Center have genetic evidence suggesting the antioxidant drugs currently used to treat lung disease, malaria and even the common cold can also help prevent and treat cancers because they fight against mitochondrial...


Luminex and Partners HealthCare Announce Collaboration Agreement

February 15, 2011 6:33 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, Feb. 15, 2011 /- Luminex Corporation (Nasdaq: LMNX ) announced today that it has teamed with Partners HealthCare toward the discovery of novel biomarkers and development of clinical assays.  This program will enable Partners HealthCare Center for Personalized Genetic...


Class I Medical Device Recall: Abbott Glucose Test Strips

February 15, 2011 6:30 am | by U.S. Food & Drug Administration | Comments

These test strips may give falsely low glucose results. False results may lead patients or health care providers to try to raise their blood glucose unnecessarily, or they may fail to treat elevated blood glucose because of a false, low reading...

Leisureworld Announces February Dividend

February 15, 2011 5:45 am | by The Associated Press | Comments

Leisureworld Senior Care Corporation (TSX: LW) today announced that the Company's dividend for February, 2011 will be $0.0708 per share, representing $0.85 per share on an annualized basis. Payment will be made on March 15, 2011 to shareholders of record February 28, 2011.About...

FDA clears ArthroCare Spartan Needled Anchor

February 15, 2011 5:45 am | by The Associated Press | Comments

Medical products maker ArthroCare Corp. said Tuesday the Food and Drug Administration cleared its Spartan 5.5 Needled Anchor, which is used to fix soft tissue to bone in procedures like a rotator cuff repair.The Austin, Texas, company said the preloaded, threaded anchor has a screw-in design...

FDA Clears First Patient-Specific Implant System for Total Knee Replacement

February 15, 2011 4:51 am | Comments

Burlington, Mass.- February 3, 2011 - ConforMIS has received 510(k) clearance from the U.S. Food and Drug Administration to commercially market its iTotal® CR Knee Replacement System.


Innovate: Fueling Change & #8212; Kids Explore Alternative Energy Resources in New Video

February 15, 2011 4:37 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., February 14, 2011 — Why should the fact that tech-based careers are cool, fun, and offer lots of opportunities in a variety of industries including green technology, continue to be a best-kept secret for young people? The SME Education Foundation has taken an...

Cellceutix settles with former CEO Evans

February 15, 2011 4:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Cellceutix Corp., a biotechnology firm in Beverly, has agreed to buy 4.6 million common stock shares, valued at about $1 million, from former CEO George W. Evans, who resigned in November amid a pay dispute with the company.

Cayenne Medical, Inc. Launches AperFix® II

February 15, 2011 4:36 am | by Bio-Medicine.Org | Comments

SCOTTSDALE, Ariz., Feb. 15, 2011 /- Cayenne Medical, Inc., a private sports medicine device company, announces the launch of AperFix® II, its second generation soft tissue repair device for multi-ligament repairs of the knee. The announcement was made today at the 2011 American...


Lanx, Inc. Announces Launch of Epicâ„¢ Anterior Thoracolumbar Plating System

February 15, 2011 4:36 am | by Bio-Medicine.Org | Comments

BROOMFIELD, Colo., Feb. 15, 2011 /- Lanx, Inc., a privately held medical device company focused on developing and commercializing innovative devices for spinal surgery, today announced the launch of its Epic™ Anterior Thoracolumbar Plating System (Epic™ System) at the 2011...


Patient-Derived Heart Cells Mimic Disease

February 15, 2011 4:34 am | by Massachusetts Institute of Technology | Comments

The cells point to new potential therapies for an inherited heart defect.


Governor Corbett Announces at Least 80 New Jobs in Lehigh Valley with Pharmaceutical Company's Purchase, Renovation of Former Amcor Site

February 15, 2011 4:34 am | by Bio-Medicine.Org | Comments

HARRISBURG, Pa., Feb. 15, 2011 /PRNewswire-USNewswire/ -- Governor Tom Corbett today announced that the global pharmaceutical company Daiichi Sankyo Inc. will create more than 80 jobs in the Lehigh Valley with the establishment of its first U.S. manufacturing and packaging operation....


Baxano, Inc. Names George A. Harter, Jr. as Chief Financial Officer

February 15, 2011 4:34 am | by Bio-Medicine.Org | Comments

SAN JOSE, Calif., Feb. 15, 2011 /- Baxano, Inc. ( w w w.b a x a no. c om ) today announced the addition of George A. Harter, Jr. to the executive team at Baxano, Inc. As Chief Financial Officer, Mr. Harter will be responsible for Finance, Administration and Human Resources. Mr. Harter...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.